03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Non-essential construction is not presently permitted in Boston, but draft best practice guidelines ...
Read More >
While courts have generally interpreted the New York City Human Rights Law (NYCHRL) as providing ant...
Read More >
The Segal Group is the premier actuarial firm in the country providing services for hundreds of mult...
Read More >
In today’s edition of Daily Compliance News: 1. In a provocative piece the NYT Dealbook explores a...
Read More >
New York partner Bradd Williamson, Global Chair of Latham’s Benefits, Compensation & Employment Pra...
Read More >
Concluding their 2019 legislative sessions, New York and Connecticut adopted sweeping new discrimina...
Read More >